Genmab A/S (GMAB)
NASDAQ: GMAB · Real-Time Price · USD
27.88
+0.22 (0.80%)
Mar 4, 2026, 12:05 PM EST - Market open

Genmab Ratios and Metrics

Millions USD. Fiscal year is Jan - Dec.
Fiscal Year
CurrentFY 2024FY 2023FY 2022FY 2021FY 2020
Period Ending
Mar '26 Dec '24 Dec '23 Dec '22 Dec '21 Dec '20
16,83988,689135,077179,484166,923171,114
Market Cap Growth
21.61%-34.34%-24.74%7.52%-2.45%83.87%
Enterprise Value
20,49970,647109,062179,484166,923171,114
Last Close Price
27.8820.8731.8442.3839.5640.66
PE Ratio
1.8112.3532.4935.6158.1829.25
Forward PE
25.46-----
PS Ratio
4.534.60-13.39--
PB Ratio
2.882.694.50---
P/TBV Ratio
-2.634.48---
P/FCF Ratio
14.6613.0520.2654.02--
P/OCF Ratio
14.2012.7419.2549.65--
EV/Sales Ratio
5.513.66-13.39--
EV/EBITDA Ratio
15.8911.08388.8929.30--
EV/EBIT Ratio
16.4011.77-30.99--
EV/FCF Ratio
17.8410.4016.3654.02--
Debt / Equity Ratio
0.020.030.02---
Debt / EBITDA Ratio
0.100.142.61---
Debt / FCF Ratio
0.120.140.11---
Asset Turnover
0.520.520---
Inventory Turnover
17.2415.760---
Quick Ratio
4.605.2413.34---
Current Ratio
6.035.2413.34---
Return on Equity (ROE)
23.54%22.30%0.00%---
Return on Assets (ROA)
16.41%13.76%0.00%---
Return on Invested Capital (ROIC)
31.18%35.43%0.00%---
Return on Capital Employed (ROCE)
21.73%17.77%0.00%---
Earnings Yield
5.72%8.10%3.08%2.81%1.72%3.42%
FCF Yield
6.82%7.66%4.94%1.85%0.00%0.00%
Buyback Yield / Dilution
2.23%3.90%0.36%0.37%0.00%0.00%
Updated Sep 30, 2025. Data Source: Fiscal.ai. Standard template. Financial Sources.
SEC Filings: 10-K · 10-Q